Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod (vol 9, e1178, 2022)-MedSci.cn

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod (vol 9, e1178, 2022)

Cabeza, VP; Kummer, LYL; Wieske, L

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022; 9 (6):

科室
- - 订阅+
  - 更多科室
工具
服务